[EN] BENZOXAZINONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS [FR] DÉRIVÉS DE BENZOXAZINONE UTILISÉS COMME AGENTS CYTOTOXIQUES SÉLECTIFS
摘要:
The present disclosure is directed to benzoxazinone derivatives of Formula I and their use for selectively killing HIV infected GAG-POL expressing cells without concomitant cytotoxicity to HIV naïve cells, and for the treatment or prophylaxis of infection by HIV, or for the treatment, prophylaxis or delay in the onset or progression of AIDS or AIDS Related Complex (ARC).
[EN] BENZOXAZINONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS [FR] DÉRIVÉS DE BENZOXAZINONE UTILISÉS COMME AGENTS CYTOTOXIQUES SÉLECTIFS
摘要:
The present disclosure is directed to benzoxazinone derivatives of Formula I and their use for selectively killing HIV infected GAG-POL expressing cells without concomitant cytotoxicity to HIV naïve cells, and for the treatment or prophylaxis of infection by HIV, or for the treatment, prophylaxis or delay in the onset or progression of AIDS or AIDS Related Complex (ARC).
Phosphine-Catalyzed [3+2] or [4+2] Cycloaddition/S<sub>N</sub>
2 Substitution Domino Reaction of <i>ortho</i>
-Aminotrifluoroaceto- phenone Derivatives with Hex-3-yn-2-one: Preparation of Functionalized 1-Benzazepine Compounds
作者:Yao-Liang Sun、Yin Wei、Min Shi
DOI:10.1002/adsc.201700778
日期:2017.9.18
In this paper, we disclose a novel strategy for the phosphine‐catalyzed cycloaddition/SN2 substitution domino reaction, giving functionalized O‐bridged benzoazepine and benzoxazepine derivatives in moderate to good yields. Changing the N–H protecting group of ortho‐aminotrifluoroacetophenone derivatives gave different bridged‐ring products in one step.
在本文中,我们公开了膦催化的环加成/ S N 2取代多米诺反应的新策略,使官能化的O桥苯并a庚因和苯并x并庚因衍生物具有中等至良好的收率。一步改变邻氨基三氟苯乙酮衍生物的NH保护基,就可以得到不同的桥环产物。
[EN] BENZOXAZINONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS<br/>[FR] DÉRIVÉS DE BENZOXAZINONE UTILISÉS COMME AGENTS CYTOTOXIQUES SÉLECTIFS
申请人:[en]MERCK SHARP & DOHME LLC
公开号:WO2023064196A1
公开(公告)日:2023-04-20
The present disclosure is directed to benzoxazinone derivatives of Formula I and their use for selectively killing HIV infected GAG-POL expressing cells without concomitant cytotoxicity to HIV naïve cells, and for the treatment or prophylaxis of infection by HIV, or for the treatment, prophylaxis or delay in the onset or progression of AIDS or AIDS Related Complex (ARC).